insights_auto
Why is ARX down 4.00%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
AU$0.48
arrow_downward
-4.00%(-0.020) 1D
ኖቬም 16, 4:10:15 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
AU$0.51
High
AU$0.51
Low
AU$0.48
Mkt. cap
166.03 ሚ
Avg. vol.
288.42 ሺ
Volume
185.28 ሺ
P/E ratio
45.80
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Open
AU$0.51
High
AU$0.51
Low
AU$0.48
Mkt. cap
166.03 ሚ
Avg. vol.
288.42 ሺ
Volume
185.28 ሺ
P/E ratio
45.80
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
BigGo Finance
·
ከ16 ሰዓቶች በፊት
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
ከ11 ሰዓቶች በፊት
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
ከ1 ቀን በፊት
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
StoneX
·
ከ2 ቀናት በፊት
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd